Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Tiuman, Tatiana Shioji ^a   Ueda Nakamura, Tânia ^a   Alonso, Antonio ^b   Nakamura, Celso Vataru ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Amastigotes; Autophagy; Cell death; Leishmania amazonensis; Parthenolide

Indexed keywords

AMPHOTERICIN B; CYCLOPHOSPHAMIDE; DANSYLCADAVERINE; PARTHENOLIDE; ANTIPROTOZOAL AGENT; SESQUITERPENE;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; AUTOPHAGY; CELL DEATH; CELL MEMBRANE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; EXOCYTOSIS; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; MALE; MICRONUCLEUS TEST; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; MUTAGENICITY; NONHUMAN; PERITONEUM MACROPHAGE; RAT; ANIMAL; BAGG ALBINO MOUSE; CELL ORGANELLE; CYTOLOGY; DRUG EFFECTS; ELECTRON MICROSCOPY; IC50; LEISHMANIA MEXICANA; ULTRASTRUCTURE;

LEISHMANIA AMAZONENSIS; MUS;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL DEATH; CELL MEMBRANE; FEMALE; INHIBITORY CONCENTRATION 50; LEISHMANIA MEXICANA; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; ORGANELLES; SESQUITERPENES;

EID: 84903556431     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-152     Document Type: Article

References (50)

1. Leishmaniasis: magnitude of the problem. WHO, World Health Org 2013 [ http://www.who.int/leishmaniasis/burden/magnitude/burden-magnitude/en/ ]
2. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Fernández-Guerrero ML, Robles P, Rivas P, Mójer F, Muñíz G, Górgolas M, Acta Trop 2004 90 11 16 10.1016/j.actatropica.2003.09.009 14739017 (Pubitemid 38117052)
3. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report. Carnaúba-Jr D, Konishi CT, Petri V, Martinez ICP, Shimizu L, Pereira-Chioccola VL, Int J Infect Dis 2009 13 504 507 10.1016/j.ijid.2009.01.022
4. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Barral A, Pedral-Sampaio D, Grimaldi Júnior G, Momen H, McMahon-Pratt D, Ribeiro De Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM, Johnson Júnior WD, Am J Trop Med Hyg 1991 44 536 546 2063957
5. Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Oliveira JPC, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, Barral A, Oliveira CI, Kinetoplastid Biol Dis 2007 doi:10.1186/1475-9292-6-5 (Pubitemid 47086717)
6. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Croft SL, Coombs GH, Trends Parasitol 2003 19 502 508 10.1016/j.pt.2003.09.008 14580961 (Pubitemid 37329659)
7. Recent advances in leishmaniasis treatment. Tiuman TS, Santos AO, Ueda-Nakamura T, Dias Filho BP, Nakamura CV, Int J Infect Dis 2011 15 525 e532 10.1016/j.ijid.2011.03.021 21605997
8. Drug resistance in leishmaniasis. Croft SL, Sundar S, Fairlamb AH, Clin Microbiol Rev 2006 19 111 126 10.1128/CMR.19.1.111-126.2006 16418526 (Pubitemid 43157649)
9. Leishmania spp.: proficiency of drug-resistant parasites. Natera S, Machuca C, Padrón-Nieves M, Romero A, Díaz E, Ponte-Sucre A, Int J Antimicrob Agents 2007 29 637 642 10.1016/j.ijantimicag.2007.01.004 17353113 (Pubitemid 46710356)
10. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Tiuman TS, Ueda-Nakamura T, Cortez DAG, Dias Filho BP, Morgado-Díaz JA, De Souza W, Nakamura CV, Antimicrob Agents Chemother 2005 49 176 182 10.1128/AAC.49.11.176-182.2005 15616293 (Pubitemid 40065790)
11. Morphologic and ultrastructural alterations in Leishmania amazonensis induced by 4a,5β-epoxy-germacra-1(10),11(13)-dien-12,6a-olide. Tiuman TS, Ueda-Nakamura T, Dias-Filho BP, Cortez DAG, Morgado-Díaz JA, Nakamura CV, Acta Protozool 2007 46 349 355
12. Uncouplers of oxidative phosphorylation can enhance a Fas death signal. Linsinger G, Wilhelm S, Wagner H, Häcker G, Mol Cell Biol 1999 19 3299 3311 10207055 (Pubitemid 29193791)
13. Evidence for boundary lipid in membranes. Jost PC, Griffith OH, Capaldi RA, Vanderkooi G, Proc Natl Acad Sci U S A 1973 70 480 484 10.1073/pnas.70.2.480 4346892
14. Are new world leishmaniases becoming anthroponoses? Rotureau B, Med Hypotheses 2006 67 1235 1241 10.1016/j.mehy.2006.02.056 16797861 (Pubitemid 44302242)
15. Urbanization: an increasing risk factor for leishmaniasis. WHO, WklyEpidemiol Rec 2002 77 365 370
16. Leishmaniasis: drug resistance and natural products (review). Polonio T, Efferth T, Int J Mol Med 2008 22 277 286 18698485
17. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Sereno D, Lemesre JL, Antimicrob Agents Chemother 1997 41 972 976 9145854 (Pubitemid 27194170)
18. Plant derived therapeutics for the treatment of leishmaniasis. Sen R, Chatterjee M, Phytomedicine 2011 18 1056 1059 10.1016/j.phymed.2011.03.004 21596544
19. Natural products as antiparasitic drugs. Kayser O, Kiderlen AF, Croft SL, Parasitol Res 2003 90 55 S62 10.1007/s00436-002-0768-3 12937967 (Pubitemid 36831279)
20. Mechanisms of membrane toxicity of hydrocarbons. Sikkema J, De Bont JAM, Poolman B, Microbiol Rev 1995 59 201 222 7603409
21. In vitro assays for evaluation of drug activity against Leishmania spp. Fumarola L, Spinelli R, Brandonisio O, Res Microbiol 2004 155 224 230 10.1016/j.resmic.2004.01.001 15142618 (Pubitemid 38624168)
22. Advances and perspectives in leishmania cell based drug-screening procedures. Sereno D, Cordeiro Da Silva A, Mathieu-Daude F, Ouaissi A, Parasitol Int 2007 56 3 7 10.1016/j.parint.2006.09.001 17079188
23. Antiprotozoal activities of Colombian plants. Weniger B, Robledo S, Arango GJ, Deharo E, Aragón R, Muñoz V, Callapa J, Lobstein A, Anton R, J Ethnopharmacol 2001 78 193 200 10.1016/S0378-8741(01)00346-4 11694364 (Pubitemid 32994787)
24. Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Weniger B, Vonthron-Sénécheau C, Kaiser M, Brun R, Anton R, Phytomedicine 2006 13 176 180 10.1016/j.phymed. 2004.10.008 16428025 (Pubitemid 43120317)
25. Formation of micronuclei in erythrocytes of the fathead minnow (Pimephales promelas) after acute treatment with mitomycin C or cyclophosphamide. Winter MJ, Ellis LCJ, Hutchinson TH, Mutat Res 2007 629 89 99 10.1016/j.mrgentox.2007.01.010 17398142 (Pubitemid 46628893)
26. Safety evaluation of proanthocyanidin polymer-rich fraction obtained from stem bark of Stryphnodendron adstringens (BARBATIMAO) for use as a pharmacological agent. Costa MA, Ishida K, Kaplum V, Koslyk ED, de Mello JC, Ueda-Nakamura T, Dias Filho BP, Nakamura CV, Regul Toxicol Pharmacol 2010 58 330 335 10.1016/j.yrtph.2010.07.006 20655967
27. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Hayashi M, MacGregor JT, Gatehouse DG, Adler I, Blakey DH, Dertinger SD, Krishna G, Morita T, Russo A, Sutou S, Environ Mol Mutagen 2000 35 234 252 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3. 0.CO;2-L 10737958 (Pubitemid 30196667)
28. Death by design: apoptosis, necrosis and autophagy. Edinger AL, Thompson CB, Curr Opin Cell Biol 2004 16 663 669 10.1016/j.ceb.2004.09.011 15530778 (Pubitemid 39463117)
29. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, et al. Autophagy 2008 4 151 175 18188003 (Pubitemid 351231180)
30. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Biederbick A, Kern HF, Elsässer HP, Eur J Cell Biol 1995 66 3 14 7750517
31. Methods for monitoring autophagy. Mizushima N, Int J Biochem Cell Biol 2004 36 2491 2502 10.1016/j.biocel.2004.02.005 15325587 (Pubitemid 39119761)
32. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. Munafó DB, Colombo MI, J Cell Sci 2001 114 3619 3629 11707514 (Pubitemid 33041044)
33. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Bera A, Singh S, Nagaraj R, Vaidya T, Mol Biochem Parasitol 2003 127 23 35 10.1016/S0166-6851(02)00300-6 12615333 (Pubitemid 36263230)
34. Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects. Cohen BE, J Membr Biol 2010 238 1 20 10.1007/s00232-010-9313-y 21085940
35. Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. Di Giorgio C, Faraut-Gambarelli F, Imbert A, Minodier P, Gasquet M, Dumon H, J Antimicrob Chemother 1999 44 71 76 10.1093/jac/44.1.71 10459812 (Pubitemid 29353684)
36. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH, Anticancer Drugs 1995 6 522 532 10.1097/00001813-199508000-00005 7579556
37. Analysis of apoptosis by propidium iodide staining and flow cytometry. Riccardi C, Nicoletti I, Nat Protoc 2006 1 1458 1461 10.1038/nprot.2006.238 17406435
38. Measurement of mitochondrial membrane potential using fluorescent rhidanmine derivatives. Scaduto RC Jr, Grotyohann LW, Biophys J 1999 76 469 477 10.1016/S0006-3495(99)77214-0 9876159 (Pubitemid 29202474)
39. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. Menna-Barreto RFS, Goncalves RLS, Costa EM, Silva RSF, Pinto AV, Oliveira MF, Castro SL, Free Radic Biol Med 2009 47 644 653 10.1016/j.freeradbiomed.2009.06.004 19501647
40. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Gottlieb E, Armour SM, Harris MH, Thompson CB, Cell Death Differ 2003 10 709 717 10.1038/sj.cdd.4401231 12761579 (Pubitemid 36675732)
41. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis. Santa-Rita RM, Henriques-Pons A, Barbosa HS, Castro SL, J Antimicrob Chemother 2004 54 704 710 10.1093/jac/dkh380 15329361 (Pubitemid 39386721)
42. NF-κB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures. Pozarowski P, Halicka DH, Darzykiewicz Z, Cytometry 2003 54A 118 124 10.1002/cyto.a.10057 (Pubitemid 37521488)
43. Effect of hydration upon the fluidity of intercellular membranes of stratum corneum: an EPR study. Alonso A, Meirelles NC, Tabak M, Biochim Biophys Acta 1995 1237 6 15 10.1016/0005-2736(95)00069-F 7619844
44. Chilling stress leads to increased cell membrane rigidity in roots of coffee (Coffea arabica L.) seedlings. Alonso A, Queiroz CS, Magalhães AC, Biochim Biophys Acta 1997 1323 75 84 10.1016/S0005-2736(96)00177-0 9030214 (Pubitemid 27051435)
45. Inhibitory effect of dipyridamole and its derivatives on lipid peroxidation in mitochondria. Nepomuceno MF, Alonso A, Pereira-da-Silva L, Tabak M, Free Radic Biol Med 1997 23 1046 1054 10.1016/S0891-5849(97)00135-4 9358248 (Pubitemid 27451292)
46. The role of pH and temperature in the development of Leishmania parasites. Zilberstein D, Annu Rev Microbiol 1994 48 449 470 10.1146/annurev.mi.48.100194.002313 7826014 (Pubitemid 24334105)
47. Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study. Ueda-Nakamura T, Attias M, Souza W, Parasitol Res 2001 87 89 97 10.1007/s004360000319 11206117 (Pubitemid 32208945)
48. Nonlinear-least-squares analysis of slow-motional EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. Budil DE, Lee S, Saxena S, Freed JH, J Magn Reson 1996 A120 155 189 (Pubitemid 126751752)
49. Effects of ethanol/L-menthol on the dynamics and partitioning of spin-labeled lipids in the stratum corneum. Dos Anjos JLV, Neto DD, Alonso A, Eur J Pharm Biopharm 2007 67 406 412 10.1016/j.ejpb.2007.02.004 17350812 (Pubitemid 47211894)
50. Terpenes increase the partitioning and molecular dynamics of an amphipathic spin label in stratum corneum membranes. Dos Anjos JLV, Alonso A, Int J Pharm 2008 350 103 112 10.1016/j.ijpharm.2007.08.024 17950546